Literature DB >> 1717939

Association of a change in chromatin structure with a tissue-specific switch in transcription start sites in the alpha 2(I) collagen gene.

K M Beck1, A H Seekamp, G R Askew, Z Mei, C M Farrell, S Wang, L N Lukens.   

Abstract

Chick embryonic sternal chondrocytes do not synthesize alpha 2(I) collagen until they are shifted by treatment with 5-bromo-2'-deoxyuridine (BrdUrd) to a fibroblastic phenotype, yet they transcribe this gene as rapidly as BrdUrd-treated cells. To examine further this transcription, the DNase I hypersensitive sites were mapped in the 5' region of this gene in chondrocytes, BrdUrd-treated chondrocytes, fibroblasts and three types of non-transcribing cells. A DNase I hypersensitive site at -200 bp, previously shown to be associated with the active transcription of this gene in fibroblasts, is not present in chondrocyte chromatin. The chondrocyte alpha 2(I) gene contains, however, a novel major hypersensitive site in the DNA region corresponding to the fibroblast intron 2, near the chondrocyte-specific transcription initiation site of this gene. This novel hypersensitive site is associated with the use of this alternate start site by chondrocytes, since it is lost when BrdUrd treatment causes these chondrocytes to switch to the initiation of transcription at the fibroblast start site. The BrdUrd-treated chondrocytes contain the same alpha 2(I) hypersensitive sites as fibroblasts, except that fibroblasts have an additional, previously unreported, site at -1000 bp.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717939      PMCID: PMC328799          DOI: 10.1093/nar/19.18.4975

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

1.  Transformation of chondroblasts by Rous sarcoma virus and synthesis of the sulfated proteoglycan matrix.

Authors:  M Pacifici; D Boettiger; K Roby; H Holtzer
Journal:  Cell       Date:  1977-08       Impact factor: 41.582

2.  Differentiation, not determination, regulates muscle gene activation: transfection of troponin I genes into multipotential and muscle lineages of 10T1/2 cells.

Authors:  S F Konieczny; C P Emerson
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

3.  Identification of a cell-specific transcriptional enhancer in the first intron of the mouse alpha 2 (type I) collagen gene.

Authors:  P Rossi; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 4.  Nuclease hypersensitive sites in chromatin.

Authors:  D S Gross; W T Garrard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

5.  Control of types I and II collagen and fibronectin gene expression in chondrocytes delineated by viral transformation.

Authors:  E S Allebach; D Boettiger; M Pacifici; S L Adams
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

6.  Restriction enzyme digestions identify discrete domains in the chromatin around the promoter of the mouse alpha 2(I) collagen gene.

Authors:  G Liau; D Szapary; C Setoyama; B de Crombrugghe
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

7.  The loss of phenotypic traits by differentiated cells, V. The effect of 5-bromodeoxyuridine on cloned chondrocytes.

Authors:  J Abbott; H Holtzer
Journal:  Proc Natl Acad Sci U S A       Date:  1968-04       Impact factor: 11.205

8.  Changes in the type II and type I collagen messenger RNA population during growth of chondrocytes in 5-bromo-2-deoxyuridine.

Authors:  P J Pawlowski; G T Brierley; L N Lukens
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

9.  Hypersensitive sites in the 5' and 3' flanking regions of the cysteine proteinase I gene of Dictyostelium discoideum.

Authors:  J Pavlovic; E Banz; R W Parish
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

10.  Analysis of changes in collagen biosynthesis that occur when chick chondrocytes are grown in 5-bromo-2'-deoxyuridine.

Authors:  R Mayne; M S Vail; E J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

View more
  7 in total

1.  Single-strand-DNA-binding factors specifically recognize the pyrimidine element in the chick alpha2(I) collagen gene promoter.

Authors:  D Bayarsaihan; L N Lukens
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

2.  Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation.

Authors:  Julie C Liu; Christopher J Lengner; Tripti Gaur; Yang Lou; Sadiq Hussain; Marci D Jones; Brent Borodic; Jennifer L Colby; Heather A Steinman; Andre J van Wijnen; Janet L Stein; Stephen N Jones; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

3.  Y-box proteins interact with the S1 nuclease-sensitive site in the chicken alpha 2(I) collagen gene promoter.

Authors:  D Bayarsaihan; B Enkhmandakh; L N Lukens
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

4.  Cloning and characterization of a novel sequence-specific single-stranded-DNA-binding protein.

Authors:  D Bayarsaihan; R J Soto; L N Lukens
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

5.  Alpha 2(I) collagen gene expression is up-regulated in quail chondrocytes pretreated with retinoic acid.

Authors:  M Sanchez; E Gionti; A Arcella; G Pontarelli; F De Lorenzo
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

6.  Elements within the beta-lactoglobulin gene inhibit expression of human serum albumin cDNA and minigenes in transfected cells but rescue their expression in the mammary gland of transgenic mice.

Authors:  I Barash; M Nathan; R Kari; N Ilan; M Shani; D R Hurwitz
Journal:  Nucleic Acids Res       Date:  1996-02-15       Impact factor: 16.971

7.  A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice.

Authors:  G Bou-Gharios; L A Garrett; J Rossert; K Niederreither; H Eberspaecher; C Smith; C Black; B Crombrugghe
Journal:  J Cell Biol       Date:  1996-09       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.